Gapping up
In reaction to strong earnings/guidance: HEI +5.7%, LEN +4.7%.
M&A news: SYNM +50.4%/ REGI +4.2% (Renewable Energy Group agrees to acquire Syntroleum; SYNM to receive 3,796,000 shares of REGI common stock). VCI +18.7% (Harland Clarke Holdings Corp. to acquire Valassis for $34.04 per share in cash).
A few European financial names showing strength: BCS +1.5%, RBS +1.3%, PUK +1.3% (light volume).
Select oil/gas related names showing strength: STO +1.3%, TOT +0.7%, PBR +0.7%, BP +0.4% (announces significant oil discovery at its Gila prospect in the deepwater US Gulf of Mexico).
A few solar names are trading higher: SPWR +2.2%, YGE +1.7%, JKS +1.5%, TSL +1.4%
Other news: ADEP +13% (announces preferred primary and secondary food packaging partnership with Harpak-ULMA), ARIA +12% (still checking), ADHD +8.9% (Alcobra Pharma: Metadoxine for the treatment of Fragile X Syndrome granted FDA orphan designation status), BCRX +8% (announced that it has selected two optimized plasma kallikrein inhibitors to advance into preclinical development as potential once-daily, oral treatments for the prevention of hereditary angioedema attacks), DAN +8% (continued strength; Dana Holding also lifts on Gabelli's reccomendation on CNBC), DHX +5% (announces new $50 mln stock repurchase program), OMER +4.8% (Omeros: Antibody inhibitor for the prevention of complement-mediated thrombotic microangiopathy receives FDA orphan designation status), CMO +4.2% (declares a $0.31 per share fourth quarter 2013 common dividend, unchanged from prior qtr), STXS +3.9% (continued strength), TWER +3.7% (continued momentum), BAK +3.2% (disclosed yesterday share sales agreement ), UBA +3% ( announces appointment of Stephan A. Rapaglia, Chief Opearting Officer), AMRS +2.7% (announces number of Sao Paulo city buses using Amyris Renewable Diesel has increased to 400 from 300; plans to produce its fragrance oil molecule from its own manufacturing facility in Brazil), NOK +2.7% (still checking; was mentioned positively on MadMoney), LPSN +2.7% (still checking), ARMH +1.9%/ ASML +1.6% (still checking), DEPO +1.4% (Nautilus Neurosciences announces the sale of CAMBIA to Depomed for up to $53.7 mln), RYAAY +1% (still checking), CNC +0.7% ( signs definitive agreement to purchase a majority stake in Fidelis SecureCare of Michigan), BBRY +0.6% (names John Sims President, Global Enterprise Services; Simms joins Blackberry in January from SAP (SAP), where he served as President of the Mobile Services business), PACD +0.4% (announces ultra-deepwater drillship Pacific Khamsin Begins Contract in Nigeria), BA +0.4% (following positive mention in Barrons), CHL +0.4% (China Mobile Chairman says company still in discussions with Apple (AAPL) regarding iPhone deal, according to reports),ABX +0.3% (announces resignation of Donald Carty and Robert Franklin from the Board of Directors, effective immediately).
Analyst comments: RRTS +2.4% (Roadrunner upgraded to Buy from Hold at Stifel), PAAS +1.4% (upgraded to Neutral from Underweight at JPMorgan), GRPN +1.2% (initiated with a Outperform at Northland Capital), SCCO +0.8% (upgraded to Buy from Neutral at Citigroup), URI +0.5% (United Rentals initiated with a Buy at Jefferies), INTC +0.2% (Intel added to the short-term buy list at Deutsche Bank)
M&A news: SYNM +50.4%/ REGI +4.2% (Renewable Energy Group agrees to acquire Syntroleum; SYNM to receive 3,796,000 shares of REGI common stock). VCI +18.7% (Harland Clarke Holdings Corp. to acquire Valassis for $34.04 per share in cash).
A few European financial names showing strength: BCS +1.5%, RBS +1.3%, PUK +1.3% (light volume).
Select oil/gas related names showing strength: STO +1.3%, TOT +0.7%, PBR +0.7%, BP +0.4% (announces significant oil discovery at its Gila prospect in the deepwater US Gulf of Mexico).
A few solar names are trading higher: SPWR +2.2%, YGE +1.7%, JKS +1.5%, TSL +1.4%
Other news: ADEP +13% (announces preferred primary and secondary food packaging partnership with Harpak-ULMA), ARIA +12% (still checking), ADHD +8.9% (Alcobra Pharma: Metadoxine for the treatment of Fragile X Syndrome granted FDA orphan designation status), BCRX +8% (announced that it has selected two optimized plasma kallikrein inhibitors to advance into preclinical development as potential once-daily, oral treatments for the prevention of hereditary angioedema attacks), DAN +8% (continued strength; Dana Holding also lifts on Gabelli's reccomendation on CNBC), DHX +5% (announces new $50 mln stock repurchase program), OMER +4.8% (Omeros: Antibody inhibitor for the prevention of complement-mediated thrombotic microangiopathy receives FDA orphan designation status), CMO +4.2% (declares a $0.31 per share fourth quarter 2013 common dividend, unchanged from prior qtr), STXS +3.9% (continued strength), TWER +3.7% (continued momentum), BAK +3.2% (disclosed yesterday share sales agreement ), UBA +3% ( announces appointment of Stephan A. Rapaglia, Chief Opearting Officer), AMRS +2.7% (announces number of Sao Paulo city buses using Amyris Renewable Diesel has increased to 400 from 300; plans to produce its fragrance oil molecule from its own manufacturing facility in Brazil), NOK +2.7% (still checking; was mentioned positively on MadMoney), LPSN +2.7% (still checking), ARMH +1.9%/ ASML +1.6% (still checking), DEPO +1.4% (Nautilus Neurosciences announces the sale of CAMBIA to Depomed for up to $53.7 mln), RYAAY +1% (still checking), CNC +0.7% ( signs definitive agreement to purchase a majority stake in Fidelis SecureCare of Michigan), BBRY +0.6% (names John Sims President, Global Enterprise Services; Simms joins Blackberry in January from SAP (SAP), where he served as President of the Mobile Services business), PACD +0.4% (announces ultra-deepwater drillship Pacific Khamsin Begins Contract in Nigeria), BA +0.4% (following positive mention in Barrons), CHL +0.4% (China Mobile Chairman says company still in discussions with Apple (AAPL) regarding iPhone deal, according to reports),ABX +0.3% (announces resignation of Donald Carty and Robert Franklin from the Board of Directors, effective immediately).
Analyst comments: RRTS +2.4% (Roadrunner upgraded to Buy from Hold at Stifel), PAAS +1.4% (upgraded to Neutral from Underweight at JPMorgan), GRPN +1.2% (initiated with a Outperform at Northland Capital), SCCO +0.8% (upgraded to Buy from Neutral at Citigroup), URI +0.5% (United Rentals initiated with a Buy at Jefferies), INTC +0.2% (Intel added to the short-term buy list at Deutsche Bank)